NCT05408780
A Phase 1, Two-part, Randomized Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of a Liquid Formulation of Tricaprilin and Matching Placebo in Healthy Subjects
Phase: Phase 1
Role: Lead Sponsor
Start: Jul 14, 2022
Completion: Oct 24, 2022